Nuzrya for CAPB or ABSSI

Nuzrya (omadacycline, Paratek®)

Indications: Adult patients with Counity-acquired bacterial pneumonia (CAPB) or acute bacterial skin and skin structure infections (ABSSI)
 

Dosage:

• CAPB
• Day 1: Intravenous infusion 200 mg/60 min or 100 mg/30 min (x2);

• Maintenance
• Intravenous Infusion: 100 mg / 30 min

• 300 mg orally once daily

• ABSSSI
• Day 1: Intravenous infusion 200 mg / 60 min or 100 mg/30 min (x2)

• Maintenance
• Intravenous Infusion: 100 mg/30 min

• 300 mg orally once daily

• Tablets
• Day 1&2: 250 mg orally once daily

• Maintanence: 300 mg orally once daily

Contraindications: Known hypersensitivity to omadacycline, tetracycline-class antibacterial drugs or any of the excipients in NUZYRA

Click here for morhttp://www.nuzyra.com/PI.pdfe prescribing information